期刊文献+

Fasl在胃癌中的表达及临床意义 被引量:2

Expression and clinical significance of fasl gene in gastric cancer
下载PDF
导出
摘要 目的:探讨胃癌组织中凋亡因子(Fasl)的表达及其与各临床病理因素的关系,评价Fasl在胃癌预后判断中的价值。方法:应用免疫组织化学Elivision法检测102例胃癌组织中Fasl的表达情况,回顾性分析Fasl与各临床病理因素及预后之间的关系。结果:胃癌组织中Fasl表达阳性率为69/102(67·6%)。低分化型胃癌的Fasl表达阳性率12/29(41·3%)明显低于分化型胃癌的阳性表达率52/73(71·2%),P<0·05;生存期<2年的患者胃癌组织中Fasl表达阳性率48/51(94·1%)明显高于生存期>5年患者的阳性表达率21/51(41·2%),P<0·01。此外Fasl表达阳性率在肿瘤部位、浸润深度及肿瘤大小等方面差异不明显,P>0·05。结论:凋亡因子Fasl在胃癌组织中具有较高的表达率,其表达与胃癌的分化类型相关。Fasl的表达状态是胃癌根治术后重要的预后因素,高表达提示预后不良。 OBJECTIVE.. To investigate the relationship between the expression of fasl and the clinicopathologic parameters in gastric carcinoma, and evaluate its significience in predicting the prognosis. METHODS: The immunohistochemical method by Ellvision was used to detect fasl expression in 102 patients with gastric carcinoma. The relationship among fasl expression and the clinicopathologic parameters and prognosis was retrospectively analyzed. RESULTS: Fas1 expression was positive in 69 of 102 cases (67.6% ). The positive rate of the expression in cases of well-differentiated metastasis was bighter than that in cases of poor-differentiated group (41.3% vs 71.2% ,P〈0. 05), being as well as the survival time (〈2 years vs 〉5 years 94.1% vs 41.2%, P〈0.01). There was no significant difference in the tumor site, tumor size and the depth of tumor invasion. CONCLUSION: Up-regulated expres- sion of apoptosis factor fasl can be found in gastric carcinoma. Fas1 expression is significantly correlated with tumor differentiation. Fas1 is an independent predictor for the patients with gastric carcinoma after radical resection.
出处 《中华肿瘤防治杂志》 CAS 2006年第20期1568-1570,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 胃肿瘤/病理学 细胞凋亡 免疫组织化学 stomach neoplasms/pathology apoptosis immunohistochemistry
  • 相关文献

参考文献3

二级参考文献11

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Yohihiro K,Blood,1995年,86期,3848页
  • 3Matsuhashi S, Yoshinaga H, Yatsuki H, et al. Isolation of a novel gene from a human cell line with Pr-28 mAb which recognizes a nuclear antigen involved in the cell cycle[J]. Res Comm Biochem Cell Mol Biol, 1997, 1(1): 109-120.
  • 4Yoshinaga H, Matsuhashi S, Ahanek J, et al. Expression and identification of H731 gene product in HeLa cells[J]. Res Commun Biochem Cell Mol Biol, 1997, 1(1): 121-131.
  • 5Lankat-Buttgereit B, Goke R. Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? [J]. Biol Cell, 2003, 95(8): 515-519.
  • 6Yang H S, Knies J L, Stark C, et al. Pded4 suppresses tumor phenotype in JB6 cells by inhibiting Ap-1 transactivation[J].Oncogene, 2003, 22(24): 3712-3720.
  • 7Goke A, Goke R, Knolle A, et al. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A[J]. Bioehem Biophys Res Commun, 2002, 297(1): 78-82.
  • 8Chen Y, Knosel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumor progression and prognosis[J]. J Pathol, 2003, 200(5): 640-646.
  • 9Yoshinaga H, Matsuhashi S, Fujiyama C, et al. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody[J]. Pathol Int, 1999, 49(12): 1067-1077.
  • 10Soejima H, Miyoshi O, Yoshinaga H, et al. Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization[J]. Cytogenet Cell Genet,1999, 87(1-2): 113-114.

共引文献29

同被引文献16

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部